Cytosorbents stock news today
WebMar 28, 2024 · Cytosorbents Co. (NASDAQ:CTSO – Get Rating) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.13 and traded as high as $3.38 ... WebFeb 10, 2024 · CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Provided by PR Newswire Jan 31, 2024 12:15 PM …
Cytosorbents stock news today
Did you know?
WebAug 8, 2024 · Following the latest downgrade, the three analysts covering Cytosorbents provided consensus estimates of US$35m revenue in 2024, which would reflect a small 7.1% decline on its sales over the... WebFind the latest CTSO stock news. View the Cytosorbents news and quotes for today, invesment news based on TipRanks market-leading research tools. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener.
WebJul 21, 2024 · Cytosorbents Market Cap $153M (-0.28%) -$0.01 A stock offering overshadowed the company's impressive preliminary second-quarter results. What … WebFind the latest news headlines from Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com. Cytosorbents Corporation Common Stock (CTSO) News Headlines …
WebApr 6, 2024 · CytoSorbents (CTSO) delivered earnings and revenue surprises of -75% and 9.78%, respectively, for the quarter ended September 2024. Do the numbers hold clues … WebOct 14, 2024 · CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification.Its flagship product, CytoSorb® is approved in the European Union with distribution in 65 ...
WebCytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor?
WebGet the latest Cytosorbents Corp (CTSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … ray ban red havanaWebCytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our … ray ban refund statusWebOct 25, 2024 · View our latest analysis for Cytosorbents. Cytosorbents is bordering on breakeven, according to the 3 American Medical Equipment analysts. They anticipate the company to incur a final loss in 2024 ... simpleplanes minecraft modWebMay 4, 2024 · CTSO stock closed at $2.18 and is down -$0.20 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CTSO has a poor overall score of 29 meaning the stock holds a better value than just 29% of stocks at its current price. ray ban red frame aviatorWebApr 12, 2024 · Cytosorbents - CTSO Institutional Ownership $3.37 -0.06 (-1.75%) (As of 03/31/2024 08:54 PM ET) Compare Today's Range $3.31 $3.50 50-Day Range $2.14 $4.17 52-Week Range $1.03 $4.59 Volume 95,300 shs Average Volume 102,911 shs Market Capitalization $147.13 million P/E Ratio N/A Dividend Yield N/A Price Target $5.75 … ray ban refurbishingWebApr 12, 2024 · What is Cytosorbents' stock price forecast for 2024? 1 Wall Street research analysts have issued 1-year target prices for Cytosorbents' shares. Their CTSO share … ray ban red polarized lensesWebView the latest Cytosorbents Corp. (CTSO) stock price, news, historical charts, analyst ratings and financial information from WSJ. ray ban refund